Pages that link to "Q33283478"

The following pages link to Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model (Q33283478):

Displaying 18 items.

• Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone (Q26785911) (← links)
• An effective solution to discover synergistic drugs for anti-cerebral ischemia from traditional Chinese medicinal formulae (Q28535072) (← links)
• Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth (Q30457642) (← links)
• Activation of the central histaminergic system is involved in hypoxia-induced stroke tolerance in adult mice. (Q33620123) (← links)
• Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation. (Q34117919) (← links)
• Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia (Q34591546) (← links)
• Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor (Q35885219) (← links)
• Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex. (Q36522633) (← links)
• Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke (Q36548207) (← links)
• Inhibition of the renin-angiotensin system and target organ protection (Q37406883) (← links)
• Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice. (Q37687150) (← links)
• Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment (Q38108717) (← links)
• Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke? (Q38819193) (← links)
• The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia (Q41064263) (← links)
• By improving regional cortical blood flow, attenuating mitochondrial dysfunction and sequential apoptosis galangin acts as a potential neuroprotective agent after acute ischemic stroke (Q48300034) (← links)
• Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats. (Q54325969) (← links)
• Angiotensin II and aldosterone-induced neuronal damage in neurons through an astrocyte-dependent mechanism (Q83799854) (← links)
• Mineralocorticoid Receptor Blockers: Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonists (Q89958005) (← links)